Low-Dose Oral Minoxidil And Topical Minoxidil: Consensus Recommendations For Managing Male And Female Pattern Hair Loss In Hair Transplant Patients Using A Modified Delphi Process

    March 2026 in “ Figshare
    Aditya K. Gupta, Mesbah Talukder, Greg Williams, Haitham Abdelhamid, Yagiz Matthew Akiska, David M. Alpeter, Scott A. Boden, Randa Erfan, Bessam Farjo, Nilofer Farjo, Steven Gabel, James A. Harris, Karl Hekimian, Sharon A. Keene, Jennifer Krejci-Manwaring, Robert T. Leonard, Luis A. Nader, Damkerng Pathomvanich, David Perez-Meza, Nicole E. Rogers, Paul T. Rose, Marie A. Schambach, Ronald L. Shapiro, Mayank Singh, Dow B. Stough, Robert H. True, Sara M. Wasserbauer, Ryan J. Welter
    New to Hair Transplant? There is a guide in the encyclopedia. Read the guide →
    Image

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary This study developed consensus guidelines for the use of low-dose oral and topical minoxidil in male and female pattern hair loss, recommending specific doses, monitoring procedures, and timing of application around hair transplant surgeries.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →